On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating the consensus of $2.21. The pharmaceutical giant reported sales of $22.47 ...

Johnson & Johnson shares initially rose Tuesday after the drugmaker reported better-than-expected third-quarter sales and raised full-year revenue guidance. However, the stock pulled back and was ...

Johnson & Johnson's Tom Aelbrecht, N-VA's Jan Jambon, Flemish Minister for Welfare and Culture ... [+] Caroline Gennez, Deputy department head of the nursing department Siska Van den Bergh, ZAS ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

How much is Johnson & Johnson stock worth? Invest with precise valuations. Get Report.

Johnson & Johnson has been a long-time partner of Save the Children. Our shared vision is a world where no child dies from preventable causes and every child has the opportunity to reach their full ...

Johnson & Johnson has been ordered to pay $15 million to a Connecticut man who claimed he developed mesothelioma, a rare form ...

The average patient saw over 80% improvement from baseline for BSA and PASI compared to those who received placebo (80.6% versus 6.1% and 82.6% versus 13.7%, respectively; p<0.001). In the third ...

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and ...

Created by Wolff Olins, the new identity sees the brand’s familiar cursive script replaced by a “modernised” mark, which is already causing wide debate Johnson & Johnson’s new identity is intended to ...

Johnson & Johnson has proposed to pay almost $9bn to resolve tens of thousands of lawsuits it faces in North America that claim its baby powder and other talc-based products cause cancer. The ...